Study Finds Drop in Exercise Among GLP-1 Users for Weight Loss
Recent research has uncovered that people taking GLP-1 medications for weight loss, such as Ozempic and Wegovy, are exercising less. This study, which is set to be presented at the Endocrine Society’s annual meeting in Chicago, shows that adults with obesity who have lost weight using these drugs have reduced their physical activity levels significantly.
Dr. Sajana Maharjan, the lead researcher from HSHS St. John’s Hospital in Springfield, Illinois, stated that drugs like semaglutide and liraglutide can lower both fat and lean muscle mass. She emphasized that regular physical activity is crucial for maintaining strength and overall health.
This study is reportedly the first to look into the link between these medications and exercise habits by analyzing data from a National Institutes of Health research program, which connected participants’ records to their fitness tracker data.
Observations
Researchers looked at 753 patients, mostly women with an average age of about 53, who had started GLP-1 treatments. They found that the average daily steps taken by participants decreased from 5,047 to 4,487, and the duration of moderate to vigorous exercise dropped from 28 minutes to 22 minutes daily. The most significant declines were noted among men and people with muscle or joint pain. Factors such as age or previous heart issues did not appear to affect these results.
Despite the common belief that losing weight would encourage more physical activity, Dr. Maharjan noted that this was not the case. “Our findings highlight that exercise must be a priority for those taking these medications,” she stated, stressing the need for programs that promote physical activity in addition to medication.
Importance of Exercise
Dr. Peter Balazs, a weight-loss specialist in New York and New Jersey, added that losing weight doesn’t automatically mean people will become more active. He explained that being in a calorie deficit can actually slow the metabolism and lead to feelings of fatigue, making it harder for individuals to exercise. Side effects from medications, like nausea, can diminish the desire to be physically active.
Balazs emphasized that for those on GLP-1 treatments, exercise isn’t optional. Incorporating strength training and daily activities, like walking, is vital for maintaining muscle mass and overall health during weight loss. He pointed out that without sufficient physical activity, a lot of weight lost may come from muscle instead of fat, which is not ideal.
Different Perspectives
However, Dr. Amanda Kahn, an internist and longevity expert, disagreed with the study’s conclusions. She argued that many patients find motivation to exercise as they lose weight. In her experience, effective treatment often requires regular follow-ups and a focus on nutrition, strength training, and comprehensive monitoring.
She believes that simply prescribing GLP-1 medications without close supervision can lead to problems. If a patient struggles with exercise or protein intake, Kahn advises adjusting the medication to ensure that preserving strength and health remains a priority.
Conclusion
This ongoing conversation emphasizes the importance of combining medication with a proactive approach to health and exercise. As the research evolves, healthcare providers and patients alike must consider how best to integrate physical activity into weight loss plans for improved long-term health.
